This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Federal Circuit sends back Promega-Life Technologies patent case

( December 15, 2014, 23:31 GMT | Official Statement) -- MLex Summary: The US Court of Appeals for the Federal Circuit has reverse a lower court’s denial of summary judgment for Life Technologies as to four patent claims asserted by Promega, determining that they are invalid for lack of enablement. The panel also reversed the court’s judgment of non-infringement as to one patent, finding that substantial evidence supported the jury’s determination of infringement against Life. Finally, the panel affirmed the district court’s finding that the license does not cover all of Life’s sales of the accused products.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections